Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2024. Go to the latest filing (Q3 2026)

30.9B USDQ4 2024
Total value of stock positions
30.9B USD
Positions
86
Share of the ten largest
35.9%

The ten largest positions Q4 2024

  1. JPMorgan Chase 5.8%▲ +102.0%
  2. U.S. Bancorp 3.8%▼ −27.3%
  3. Visa Inc. 3.6%▼ −0.3%
  4. Bank of America 3.5%▲ +23.8%
  5. Charles Schwab Corporation 3.5%▲ +526.5%
  6. Intuit 3.5%▲ +492.9%
  7. Microsoft 3.3%▲ +16.9%
  8. Fortive 3.2%▲ +11.8%
  9. UnitedHealth Group 3.1%new
  10. DoorDash 2.7%▲ +37.5%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2024

Positions Q4 2024 per 13F filing, 86 of 86
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 1.9% 2,614,074 573.5M USD −35.5% reduced Q2 2015 39 quarters
Bridgebio Pharma Inc 2.2% 25,120,991 689.3M USD unchanged Q2 2019 23 quarters
Adaptive Biotechnologies Cor 0.6% 29,993,708 179.8M USD unchanged Q2 2019 23 quarters
FTV Fortive 3.2% 13,193,368 989.5M USD +11.8% increased Q3 2019 22 quarters
Api Group Corp 2.5% 21,537,518 774.7M USD −16.2% reduced Q2 2020 19 quarters
Royalty Pharma PLC 1.0% 12,207,885 311.4M USD +0.9% increased Q2 2020 19 quarters
Pharvaris N V 0.2% 3,653,310 70.0M USD unchanged Q1 2021 16 quarters
Edgewise Therapeutics Inc 0.1% 1,224,986 32.7M USD −17.3% reduced Q1 2021 16 quarters
Rallybio Corp < 0.1% 4,194,777 4.0M USD unchanged Q3 2021 14 quarters
Biomarin Pharmaceutical Inc 2.2% 10,510,550 690.9M USD +7.8% increased Q4 2021 13 quarters
Roivant Sciences Ltd 1.8% 47,809,960 565.6M USD −11.6% reduced Q4 2021 13 quarters
PGR Progressive Corporation 1.7% 2,173,703 520.8M USD −37.6% reduced Q1 2022 12 quarters
Pepgen Inc < 0.1% 1,482,434 5.6M USD unchanged Q2 2022 11 quarters
Trevi Therapeutics Inc < 0.1% 4,400,000 18.1M USD unchanged Q3 2022 10 quarters
CSX CSX Corporation 1.5% 14,672,537 473.5M USD +56.9% increased Q4 2022 9 quarters
Newamsterdam Pharma Company 0.6% 6,978,534 179.3M USD −13.0% reduced Q4 2022 9 quarters
PM Philip Morris International 2.0% 5,087,950 612.3M USD −43.8% reduced Q2 2023 7 quarters
USB U.S. Bancorp 3.8% 24,447,757 1.2B USD −27.3% reduced Q4 2023 5 quarters
HCA HCA Healthcare 1.1% 1,110,230 333.2M USD +59.1% increased Q4 2023 5 quarters
TMUS T-Mobile US 0.4% 610,404 134.7M USD −47.0% reduced Q4 2023 5 quarters
Regal Rexnord Corporation 0.4% 866,612 134.4M USD +37.5% increased Q4 2023 5 quarters
KKR KKR & Co. 0.4% 875,778 129.5M USD −51.6% reduced Q4 2023 5 quarters
TEAM Atlassian 0.4% 496,185 120.8M USD −83.3% reduced Q4 2023 5 quarters
MSFT Microsoft 3.3% 2,390,300 1.0B USD +16.9% increased Q1 2024 4 quarters
ADBE Adobe Inc. 1.8% 1,234,688 549.0M USD −52.9% reduced Q1 2024 4 quarters
CPT Camden Property Trust 1.3% 3,362,401 390.2M USD +13.6% increased Q1 2024 4 quarters
Integer HLDGS Corp 0.5% 1,155,711 153.2M USD +4.1% increased Q1 2024 4 quarters
Standard Biotools Inc 0.3% 58,651,170 102.6M USD unchanged Q1 2024 4 quarters
OSCR Oscar Health 0.1% 3,073,765 41.3M USD −50.2% reduced Q1 2024 4 quarters
Equitable HLDGS Inc 0.1% 764,323 36.1M USD −74.9% reduced Q1 2024 4 quarters
Oric Pharmaceuticals Inc 0.1% 4,431,008 35.8M USD +10.8% increased Q1 2024 4 quarters
Immunovant Inc 0.1% 1,407,290 34.9M USD −39.4% reduced Q1 2024 4 quarters
JPM JPMorgan Chase 5.8% 7,466,187 1.8B USD +102.0% increased Q2 2024 3 quarters
INTU Intuit 3.5% 1,718,964 1.1B USD +492.9% increased Q2 2024 3 quarters
DASH DoorDash 2.7% 4,949,392 830.3M USD +37.5% increased Q2 2024 3 quarters
Spotify Technology S A 2.2% 1,548,585 692.8M USD −39.9% reduced Q2 2024 3 quarters
NFLX Netflix 1.4% 502,298 447.7M USD +145.0% increased Q2 2024 3 quarters
CRM Salesforce 1.3% 1,211,482 405.0M USD +122.5% increased Q2 2024 3 quarters
ALL Allstate 1.2% 1,937,242 373.5M USD −5.1% reduced Q2 2024 3 quarters
NVDA Nvidia 0.9% 2,031,985 272.9M USD −10.3% reduced Q2 2024 3 quarters
SHW Sherwin-Williams 0.7% 618,022 210.1M USD −52.5% reduced Q2 2024 3 quarters
CVNA Carvana 0.6% 873,583 177.7M USD +224.6% increased Q2 2024 3 quarters
GEV GE Vernova 0.4% 361,475 118.9M USD −64.3% reduced Q2 2024 3 quarters
Inhibrx Biosciences Inc < 0.1% 1,787,705 27.5M USD unchanged Q2 2024 3 quarters
V Visa Inc. 3.6% 3,495,090 1.1B USD −0.3% reduced Q3 2024 2 quarters
BAC Bank of America 3.5% 24,715,946 1.1B USD +23.8% increased Q3 2024 2 quarters
SCHW Charles Schwab Corporation 3.5% 14,658,944 1.1B USD +526.5% increased Q3 2024 2 quarters
CMCSA Comcast 2.4% 19,818,985 743.8M USD +540.8% increased Q3 2024 2 quarters
GOOGL Alphabet Inc. (Class A) 2.2% 3,661,375 693.1M USD +186.6% increased Q3 2024 2 quarters
MET MetLife 1.6% 6,017,040 492.7M USD +34.1% increased Q3 2024 2 quarters
SBUX Starbucks 1.6% 5,344,064 487.6M USD +220.9% increased Q3 2024 2 quarters
Flutter Entmt PLC 1.6% 1,868,698 483.0M USD −26.6% reduced Q3 2024 2 quarters
Transunion 1.2% 4,100,233 380.1M USD +70.8% increased Q3 2024 2 quarters
SNPS Synopsys 1.1% 721,318 350.1M USD +105.2% increased Q3 2024 2 quarters
AON Aon plc 0.8% 720,364 258.7M USD +27.9% increased Q3 2024 2 quarters
ADSK Autodesk 0.7% 756,584 223.6M USD −0.7% reduced Q3 2024 2 quarters
BSX Boston Scientific 0.6% 2,172,208 194.0M USD +124.6% increased Q3 2024 2 quarters
ZS Zscaler 0.5% 914,969 165.1M USD +7.9% increased Q3 2024 2 quarters
Teva Pharmaceutical Inds Ltd 0.5% 6,503,485 143.3M USD −14.1% reduced Q3 2024 2 quarters
LI Li Auto 0.4% 4,593,756 110.2M USD +121.4% increased Q3 2024 2 quarters
Biontech SE 0.3% 940,850 107.2M USD +1,932.3% increased Q3 2024 2 quarters
CSGP CoStar Group 0.3% 1,162,703 83.2M USD −7.8% reduced Q3 2024 2 quarters
VST Vistra Corp. 0.3% 601,501 82.9M USD −67.3% reduced Q3 2024 2 quarters
Ginkgo Bioworks Holdings Inc 0.1% 3,577,128 35.1M USD unchanged Q3 2024 2 quarters
UNH UnitedHealth Group 3.1% 1,900,457 961.4M USD new Q4 2024 1 quarter
TSM Taiwan Semiconductor Manufacturing (ADR) 2.6% 4,089,619 807.7M USD new Q4 2024 1 quarter
BA Boeing 1.7% 2,975,071 526.6M USD new Q4 2024 1 quarter
MNST Monster Beverage 1.4% 8,064,361 423.9M USD new Q4 2024 1 quarter
ICE Intercontinental Exchange 1.3% 2,767,493 412.4M USD new Q4 2024 1 quarter
ROST Ross Stores 0.8% 1,706,953 258.2M USD new Q4 2024 1 quarter
Skechers U S A Inc 0.8% 3,621,391 243.5M USD new Q4 2024 1 quarter
American Airls Group Inc 0.8% 13,539,994 236.0M USD new Q4 2024 1 quarter
COO Cooper Companies (The) 0.6% 2,025,310 186.2M USD new Q4 2024 1 quarter
AMT American Tower 0.5% 897,340 164.6M USD new Q4 2024 1 quarter
TRV Travelers Companies (The) 0.5% 671,750 161.8M USD new Q4 2024 1 quarter
GM General Motors 0.4% 2,580,242 137.4M USD new Q4 2024 1 quarter
APO Apollo Global Management 0.3% 569,435 94.0M USD new Q4 2024 1 quarter
TWLO Twilio 0.3% 838,385 90.6M USD new Q4 2024 1 quarter
CHTR Charter Communications 0.3% 251,441 86.2M USD new Q4 2024 1 quarter
APTV Aptiv 0.2% 1,024,222 61.9M USD new Q4 2024 1 quarter
SNAP Snap 0.2% 5,298,559 57.1M USD new Q4 2024 1 quarter
Travere Therapeutics Inc 0.2% 2,901,925 50.6M USD new Q4 2024 1 quarter
QCOM Qualcomm 0.2% 322,814 49.6M USD new Q4 2024 1 quarter
APP AppLovin 0.2% 148,965 48.2M USD new Q4 2024 1 quarter
LULU Lululemon Athletica 0.1% 83,105 31.8M USD new Q4 2024 1 quarter
Pony AI Inc < 0.1% 739,797 10.6M USD new Q4 2024 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 28.1%
  • Technology 15.7%
  • Consumer Discretionary 8.3%
  • Communication Services 7.2%
  • Industrials 6.8%
  • Health Care 5.4%
  • Consumer Staples 3.4%
  • Real Estate 2.1%
  • Materials 0.7%
  • Utilities 0.3%
  • not in our coverage 22.2%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close